Nano-NRTIs: Efficient Inhibitors of HIV Type-1 in Macrophages with a Reduced Mitochondrial Toxicity
Antiviral chemistry & chemotherapy2010Vol. 21(1), pp. 1–14
Citations Over TimeTop 23% of 2010 papers
Serguei V. Vinogradov, Larisa Y. Poluektova, Edward Makarov, Trevor Gerson, Madapathage T. Senanayake
Abstract
Nano-NRTIs demonstrated a promising antiviral efficacy against HIV-1 in MDMs and showed strong potential as nanocarriers for delivery of antiviral drugs to macrophages harbouring in the brain.
Related Papers
- → Prevalence and Characteristics of Multinucleoside-Resistant Human Immunodeficiency Virus Type 1 among European Patients Receiving Combinations of Nucleoside Analogues(2000)95 cited
- → Stavudine, Didanosine, and Zalcitabine(2006)4 cited
- Pharmacokinetics of stavudine by oral administration to healthy Mexican volunteers.(2003)
- → HIV-1 Reverse Transcriptase Mutations Found in a Drug-Experienced Patient Confer Reduced Susceptibility to Multiple Nucleoside Reverse Transcriptase Inhibitors(2002)3 cited
- Contraindicated antiretroviral drug combinations.(2002)